Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Central Nervous System Stimulants | 1 | 2023 | 216 | 0.760 |
Why?
|
| Survival Analysis | 1 | 2022 | 1538 | 0.630 |
Why?
|
| HIV Infections | 1 | 2023 | 772 | 0.510 |
Why?
|
| Salmonella enterica | 4 | 2015 | 8 | 0.500 |
Why?
|
| Begomovirus | 1 | 2014 | 1 | 0.490 |
Why?
|
| Insect Control | 1 | 2014 | 4 | 0.490 |
Why?
|
| Hemiptera | 1 | 2014 | 7 | 0.480 |
Why?
|
| Insecticides | 1 | 2014 | 27 | 0.480 |
Why?
|
| Agricultural Irrigation | 4 | 2015 | 4 | 0.420 |
Why?
|
| Fruit | 4 | 2017 | 75 | 0.410 |
Why?
|
| Tumor Hypoxia | 2 | 2022 | 29 | 0.410 |
Why?
|
| Food Contamination | 4 | 2017 | 31 | 0.330 |
Why?
|
| Prostatic Neoplasms | 3 | 2023 | 1721 | 0.300 |
Why?
|
| Computer Simulation | 2 | 2022 | 1078 | 0.280 |
Why?
|
| Salmonella | 2 | 2017 | 14 | 0.280 |
Why?
|
| Ponds | 2 | 2015 | 2 | 0.260 |
Why?
|
| Misonidazole | 2 | 2022 | 17 | 0.250 |
Why?
|
| Stroke | 2 | 2023 | 965 | 0.250 |
Why?
|
| Gender Identity | 1 | 2023 | 52 | 0.230 |
Why?
|
| Rural Population | 1 | 2023 | 136 | 0.220 |
Why?
|
| Patient Transfer | 1 | 2023 | 91 | 0.220 |
Why?
|
| Febrile Neutropenia | 1 | 2022 | 14 | 0.210 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 181 | 0.210 |
Why?
|
| Zinc | 1 | 2021 | 91 | 0.200 |
Why?
|
| Neoplasms | 3 | 2022 | 2898 | 0.200 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2021 | 56 | 0.200 |
Why?
|
| Humans | 23 | 2023 | 86643 | 0.200 |
Why?
|
| Pneumonia | 1 | 2022 | 179 | 0.200 |
Why?
|
| Probability | 1 | 2022 | 355 | 0.190 |
Why?
|
| Respiratory Insufficiency | 1 | 2022 | 150 | 0.190 |
Why?
|
| Rectum | 1 | 2021 | 146 | 0.190 |
Why?
|
| Brachytherapy | 1 | 2021 | 119 | 0.190 |
Why?
|
| Symptom Assessment | 1 | 2020 | 65 | 0.190 |
Why?
|
| Antibody Formation | 1 | 2020 | 171 | 0.180 |
Why?
|
| Triiodothyronine | 1 | 2021 | 339 | 0.180 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2022 | 294 | 0.180 |
Why?
|
| Dietary Supplements | 2 | 2018 | 128 | 0.180 |
Why?
|
| Mesothelioma | 1 | 2022 | 311 | 0.170 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 293 | 0.170 |
Why?
|
| Male | 11 | 2023 | 40965 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 413 | 0.170 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 275 | 0.170 |
Why?
|
| Oxygen | 2 | 2021 | 726 | 0.170 |
Why?
|
| Quercetin | 1 | 2018 | 3 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2018 | 10 | 0.160 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1621 | 0.160 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 266 | 0.160 |
Why?
|
| Health Personnel | 1 | 2020 | 202 | 0.160 |
Why?
|
| Community Health Centers | 1 | 2019 | 113 | 0.160 |
Why?
|
| Patient Care Team | 1 | 2020 | 280 | 0.150 |
Why?
|
| Digestion | 1 | 2017 | 7 | 0.150 |
Why?
|
| Animal Feed | 1 | 2017 | 20 | 0.150 |
Why?
|
| Health Promotion | 1 | 2019 | 160 | 0.150 |
Why?
|
| Milk | 1 | 2017 | 53 | 0.150 |
Why?
|
| Dietary Fiber | 1 | 2017 | 43 | 0.150 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 136 | 0.150 |
Why?
|
| Enzymes | 1 | 2017 | 47 | 0.150 |
Why?
|
| Female | 10 | 2023 | 44532 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2019 | 328 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2019 | 319 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 1076 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 878 | 0.130 |
Why?
|
| Electron Spin Resonance Spectroscopy | 3 | 2022 | 306 | 0.130 |
Why?
|
| Capsicum | 1 | 2014 | 2 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2023 | 8489 | 0.130 |
Why?
|
| Colitis, Ulcerative | 1 | 2021 | 711 | 0.130 |
Why?
|
| Fertilizers | 1 | 2014 | 8 | 0.120 |
Why?
|
| Vegetables | 1 | 2014 | 45 | 0.120 |
Why?
|
| Salmonella Food Poisoning | 1 | 2013 | 4 | 0.120 |
Why?
|
| Bacteriological Techniques | 1 | 2014 | 39 | 0.120 |
Why?
|
| Nitrogen | 1 | 2014 | 70 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 1169 | 0.120 |
Why?
|
| Adult | 5 | 2023 | 25648 | 0.110 |
Why?
|
| Potassium | 1 | 2014 | 281 | 0.110 |
Why?
|
| Physicians | 1 | 2020 | 673 | 0.110 |
Why?
|
| Aged | 7 | 2023 | 18415 | 0.110 |
Why?
|
| Middle Aged | 8 | 2023 | 25028 | 0.110 |
Why?
|
| Hypoxia | 3 | 2022 | 641 | 0.100 |
Why?
|
| Drug Therapy, Combination | 2 | 2023 | 894 | 0.090 |
Why?
|
| Positron-Emission Tomography | 2 | 2022 | 329 | 0.090 |
Why?
|
| Prostate | 2 | 2023 | 378 | 0.090 |
Why?
|
| Seasons | 3 | 2015 | 223 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3362 | 0.070 |
Why?
|
| Food Handling | 2 | 2017 | 5 | 0.070 |
Why?
|
| Time Factors | 3 | 2023 | 5210 | 0.070 |
Why?
|
| United States | 3 | 2023 | 6672 | 0.070 |
Why?
|
| Animals | 4 | 2022 | 26582 | 0.070 |
Why?
|
| Cerebral Infarction | 1 | 2023 | 71 | 0.060 |
Why?
|
| Margins of Excision | 1 | 2022 | 39 | 0.050 |
Why?
|
| Aspirin | 1 | 2023 | 156 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2023 | 134 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 61 | 0.050 |
Why?
|
| Motion | 1 | 2022 | 85 | 0.050 |
Why?
|
| Quality of Life | 2 | 2021 | 1585 | 0.050 |
Why?
|
| Radiologists | 1 | 2022 | 46 | 0.050 |
Why?
|
| Compliance | 1 | 2021 | 23 | 0.050 |
Why?
|
| Immunity | 1 | 2022 | 136 | 0.050 |
Why?
|
| Cell Hypoxia | 1 | 2022 | 164 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2023 | 223 | 0.050 |
Why?
|
| Acute Disease | 1 | 2023 | 826 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2022 | 117 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2022 | 180 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2021 | 77 | 0.050 |
Why?
|
| Pressure | 1 | 2021 | 165 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2022 | 468 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2020 | 71 | 0.050 |
Why?
|
| Gastrectomy | 1 | 2021 | 68 | 0.050 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2021 | 73 | 0.050 |
Why?
|
| Radiotherapy Dosage | 1 | 2021 | 468 | 0.050 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2021 | 86 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2022 | 170 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 859 | 0.050 |
Why?
|
| Pharmacists | 1 | 2020 | 32 | 0.050 |
Why?
|
| Uterus | 1 | 2021 | 215 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 112 | 0.050 |
Why?
|
| Hypothyroidism | 1 | 2021 | 232 | 0.050 |
Why?
|
| Nigeria | 1 | 2020 | 152 | 0.040 |
Why?
|
| Registries | 1 | 2023 | 702 | 0.040 |
Why?
|
| Genotype | 2 | 2015 | 1851 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 484 | 0.040 |
Why?
|
| Population Health | 1 | 2019 | 33 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2023 | 398 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 456 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 860 | 0.040 |
Why?
|
| Mice | 2 | 2022 | 11352 | 0.040 |
Why?
|
| Dairying | 1 | 2017 | 3 | 0.040 |
Why?
|
| Endo-1,4-beta Xylanases | 1 | 2017 | 3 | 0.040 |
Why?
|
| Cellulase | 1 | 2017 | 2 | 0.040 |
Why?
|
| Poverty | 1 | 2019 | 173 | 0.040 |
Why?
|
| Milk Proteins | 1 | 2017 | 24 | 0.040 |
Why?
|
| Lipid Droplets | 1 | 2017 | 16 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1823 | 0.040 |
Why?
|
| Glycolipids | 1 | 2017 | 29 | 0.040 |
Why?
|
| Lactation | 1 | 2017 | 53 | 0.040 |
Why?
|
| Humidity | 1 | 2017 | 89 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1805 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1673 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2020 | 7993 | 0.040 |
Why?
|
| Cattle | 1 | 2017 | 376 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 1939 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 740 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2022 | 1204 | 0.030 |
Why?
|
| Eating | 1 | 2017 | 166 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2705 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2017 | 234 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1801 | 0.030 |
Why?
|
| Temperature | 1 | 2017 | 396 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2015 | 16 | 0.030 |
Why?
|
| Georgia | 1 | 2015 | 34 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2015 | 17 | 0.030 |
Why?
|
| Florida | 1 | 2015 | 55 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 839 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2015 | 71 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 143 | 0.030 |
Why?
|
| Chicago | 1 | 2019 | 1379 | 0.030 |
Why?
|
| Food Microbiology | 1 | 2013 | 9 | 0.030 |
Why?
|
| Culture Media | 1 | 2014 | 147 | 0.030 |
Why?
|
| Bacterial Typing Techniques | 1 | 2013 | 28 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 685 | 0.030 |
Why?
|
| Diet | 1 | 2017 | 443 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1753 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 4213 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2013 | 193 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 6509 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2601 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 927 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 1718 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 5417 | 0.020 |
Why?
|
| Child | 1 | 2022 | 6927 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 5976 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 746 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1991 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 8981 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1578 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2015 | 1351 | 0.020 |
Why?
|